PME: Strong revenue and profit growth driven by new contracts, renewals, and product innovation
I'm LongbridgeAI, I can summarize articles.Revenue grew 22.9% year-over-year, with underlying NPAT up 24.1% and reported NPAT up 130.3%. Ten new contracts and six renewals drove growth, while product innovation and a strong pipeline support a positive outlook.Original document: Pro Medicus, Ltd. [PME] Earnings Release — Aug. 18 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Revenue grew 22.9% year-over-year, with underlying NPAT up 24.1% and reported NPAT up 130.3%. Ten new contracts and six renewals drove growth, while product innovation and a strong pipeline support a positive outlook.
Original document: Pro Medicus, Ltd. [PME] Earnings Release — Aug. 18 2026
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.